Clorox upped its adjusted earnings per share guidance for the fiscal year to a new range of $6.95 to $7.35, a year-over-year ...

Bill Ackman is one of the most widely followed investment managers in the world. He's in charge of Pershing Square Capital, a ...

If this sounds like the investment mentality you adopt, continue reading. Here's the ultimate growth stock to buy with $1,000 ...

But right now, you're in luck. Here's one Magnificent Seven stock you should buy on the dip without hesitation. And just so ...

The company found tremendous success. Unit volume soared 134% in the past five years, between the third quarters of 2019 and ...

Since average earnings tend to rise over time, you'd expect to see younger workers -- those with higher average monthly ...

By contrast, Novo Nordisk is both the developer and seller of Wegovy, while Viking Therapeutics's VK2735 has posted impressive results in testing and is now in the later stages of development. Wegovy ...

Explore the exciting world of Snowflake ( SNOW 1.14%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and ...

Inspire Medical Systems ( INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Both Guggenheim's Yatin Suneja and Wainwright's Andrew Fein were more modest in their Neurocrine price target cuts, with the former shaving $2 off his target to $163 per share and the latter reducing ...

During the three-month period that ended Dec. 31, 2024, Chipotle increased revenue 13.1% year over year to $2.8 billion. That ...

News of a significant price-target boost from an analyst tracking GDS Holdings ( GDS 7.20%) was the main catalyst behind the ...